FridayJun 05, 2026 9:45 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Targets Growing Need for Non-Invasive Intoxication Detection 

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio Therapeutics is developing AI-powered voice analysis technology designed to detect drug and alcohol impairment from short speech samples. The platform analyzes more than 140 acoustic markers and has been trained on a dataset exceeding 50 million data points. Mining operations in South America represent the company’s initial commercial focus, where workforce safety and high-volume screening requirements create operational challenges. Potential applications extend beyond mining into aviation, construction, law enforcement, call centers, transportation, and mental health settings. The global alcohol and drug testing devices…

Continue Reading

FridayJun 05, 2026 9:00 am

Numa Numa Resources Inc. Committed to Advancing Bougainville Infrastructure Alongside Mining Development

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements. Today many mining projects are designed with a wider development mandate, recognizing that infrastructure can generate benefits extending well beyond the life of a mine. Numa Numa Resources has positioned infrastructure development as a central component of its strategy. The company’s infrastructure efforts are occurring alongside agreements with landowners connected to the Panguna resource area. Modern mining projects are no longer judged solely by the minerals they produce. Increasingly, companies are being evaluated on the roads they build, the power systems they create and the long-term economic…

Continue Reading

ThursdayJun 04, 2026 11:15 am

Democratizing the Space Economy: How Public Investment Vehicles Are Opening Private Orbital Opportunities

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising. Traditionally, many significant investment opportunities in the space industry were only accessible to venture capital and institutional investors, leaving retail investors unable to participate. However, Planet Ventures Inc. is changing this, as the company provides shareholders with indirect exposure to private space and aerospace companies through a publicly traded investment vehicle. A variety of companies stretch under Planet Ventures’ belt, including areas like software, energy, robotics, emerging applications, and infrastructure. The commercial space economy is entering a new phase of growth. What was once dominated…

Continue Reading

ThursdayJun 04, 2026 9:45 am

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Marks Significant Milestone with Ocean Partners UK Ltd. Definitive Gold and Silver Dore Purchase Agreement

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising. ESGold Corp., a development-stage company committed to the acquisition, exploration, and development of high-quality mineral properties worldwide, just entered into a definitive gold and silver dore purchase agreement with Ocean Partners UK Ltd. Ocean Partners will purchase 100% of ESGold’s dore production, in exchange for a non-dilutive working capital facility of up to C$9 million Delivery of the dore will be made EXW at the Montauban Project Mine site, with Ocean Partners responsible for collection and related logistics The agreement was based on prevailing LBMA…

Continue Reading

ThursdayJun 04, 2026 9:00 am

Regentis Biomaterials Ltd. (NYSE American: RGNT): Could GelrinC Become the First Widely Adopted Off-the-Shelf Regenerative Cartilage Repair Platform?

Humanitas collaboration supports Regentis' physician adoption strategy and broader commercial infrastructure across the European market. GelrinC targets a large orthopedic market that currently lacks an approved off-the-shelf regenerative cartilage repair solution. Pivotal FDA enrollment, manufacturing scale-up, physician engagement initiatives and CE Mark status position the company toward multiple potential value-inflection milestones. Regenerative medicine has long promised to transform patient care, but investors often become most interested when innovative science begins transitioning toward commercial adoption. Regentis Biomaterials (NYSE American: RGNT) is approaching that transition with GelrinC(R), its cartilage regeneration platform targeting a large orthopedic market where treatment alternatives continue to involve…

Continue Reading

WednesdayJun 03, 2026 10:30 am

Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) Strengthens Position in Rapidly Growing Rare Earth Sector

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising. The importance of rare earth elements has grown significantly alongside the global energy transition. Canamera Energy Metals is accelerating exploration activities at its Turvolândia rare earth project in Minas Gerais, Brazil.  The company also filed an independent NI 43-101 technical report for its Jaguaribe rare earth project in Ceará State, Brazil. Rare earth elements are becoming increasingly essential to the modern global economy, powering technologies that range from electric vehicles and renewable energy systems to advanced defense applications and consumer electronics. As governments…

Continue Reading

WednesdayJun 03, 2026 9:45 am

Earth Science Tech Inc. (ETST) Pairs Healthcare Expansion with Aggressive Share Repurchases 

Earth Science Tech has evolved into a diversified healthcare holding company with operations spanning telemedicine, compounding pharmacies, clinical support services and healthcare fulfillment. In addition, the company has actively reduced its share count through a series of share repurchases documented in SEC filings and share structure records. Earth Science Tech repurchased 3.7 million shares over the nine months ended December 31, 2025, spending approximately $647,000. Management continues to emphasize shareholder value through balance-sheet management alongside acquisitions and operating growth. The company is scheduled to present to investors at the Planet MicroCap Las Vegas 2026 conference in June. For many investors…

Continue Reading

WednesdayJun 03, 2026 9:00 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Builds Diversified Pipeline Across Neurological and Wellness Markets

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. The growing burden of neurological disease has intensified industry-wide interest in therapies capable of protecting neurons, preserving brain function and addressing disease progression at a biological level. Quantum BioPharma’s flagship pharmaceutical subsidiary, Lucid Psycheceuticals Inc., is advancing LUCID-MS, a patented new chemical entity being developed for an unmet need in multiple sclerosis. The company has also expanded its presence in a consumer ready product in the field of alcohol health and sobriety through its involvement with unbuzzd(TM), an innovative, clinically validated alcohol metabolism accelerator…

Continue Reading

TuesdayJun 02, 2026 10:30 am

Boots on the Ground: How SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Is Embedding Itself in the World’s Most Active Drone War

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. SPARC AI’s establishment of a wholly owned Ukrainian subsidiary marks a shift from distributor-led expansion to direct execution in one of the most operationally demanding drone warfare environments in the world. Ukraine’s battlefield conditions, including persistent GPS jamming and rapid drone deployment cycles, create a real-world proving ground few defense technology companies can replicate. With manufacturer partnerships, operator relationships, and a permanent in-country team, SPARC AI is building both distribution infrastructure and field validation simultaneously. Modern warfare is increasingly being shaped by software rather…

Continue Reading

TuesdayJun 02, 2026 9:45 am

Public Markets and Private Space: How Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) Is Positioning for the Sector’s Next Capital Cycle

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising. Private investment in the space sector reached record levels in 2025, with momentum expected to continue as defense spending, sovereign satellite investment, and launch infrastructure demand accelerate. Planet Ventures is pursuing a public-market investment model designed to give shareholders access to private aerospace and space technology companies that have historically been the domain of venture and institutional capital. The company's growing portfolio spans launch systems, orbital infrastructure, satellite-adjacent technologies, and aerospace innovation across multiple segments of the expanding space economy. The global space economy is…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered